Literature DB >> 30194648

Astrocytic degeneration in chronic traumatic encephalopathy.

Eric T Hsu1, Mihika Gangolli2, Shiran Su2, Laurena Holleran1,3, Thor D Stein4,5,6, Victor E Alvarez4,5,6, Ann C McKee4,5,6,7, Robert E Schmidt8, David L Brody9,10,11,12,13.   

Abstract

Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with repeated head traumas. Using immunohistochemistry for glial fibrillary acidic protein as a marker, plus automated quantitative analysis, we examined the characteristics and extent of astrogliosis present in stage III and IV CTE, along with Alzheimer's disease (AD), and frontotemporal dementia (FTD) cases. Astrogliosis in CTE patients was more diffuse compared to that of AD and FTD patients, which was concentrated in the sulcal depths. Of 14 patients with CTE, 10 exhibited signs of a degenerating astrocyte pathology, characterized by beaded, broken astrocytic processes. This astrocytic degeneration was typically found to be diffuse throughout the white matter, although two cases demonstrated astrocytic degeneration in the gray matter. The degeneration was also observed in 2 of 3 AD and 2 of 3 FTD brains, with overall similar characteristics across diseases. There was minimal to no astrocytic degeneration in six age-matched controls with no neurodegenerative disease. We found that the extent of the white matter astrocytic degeneration was strongly correlated with the level of overall astrogliosis in both the white and gray matter. However, astrocytic degeneration was not correlated with the overall extent of tau pathology. Specifically, there was no correlation between levels of p-tau in the sulcal depths and astrocytic degeneration in the white matter adjacent to the sulcal depths. Thus, astrocytic degeneration and overall astrogliosis appear to represent distinct pathological features of CTE. Further investigation into these astroglial pathologies could provide new insights into underlying disease mechanisms and represent a potential target for in vivo assessment of CTE as well as other neurodegenerative disorders.

Entities:  

Keywords:  Astrocyte; Chronic traumatic encephalopathy; Glial fibrillary acidic protein; Neurodegeneration

Mesh:

Substances:

Year:  2018        PMID: 30194648     DOI: 10.1007/s00401-018-1902-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  23 in total

1.  Generation and Characterization of Novel Monoclonal Antibodies Targeting p62/sequestosome-1 Across Human Neurodegenerative Diseases.

Authors:  Jorge A Trejo-Lopez; Zachary A Sorrentino; Cara J Riffe; Stefan Prokop; Dennis W Dickson; Anthony T Yachnis; Benoit I Giasson
Journal:  J Neuropathol Exp Neurol       Date:  2020-04-01       Impact factor: 3.685

2.  Mild Chronic Traumatic Encephalopathy Neuropathology in People With No Known Participation in Contact Sports or History of Repetitive Neurotrauma.

Authors:  Grant L Iverson; Teemu M Luoto; Pekka J Karhunen; Rudolph J Castellani
Journal:  J Neuropathol Exp Neurol       Date:  2019-07-01       Impact factor: 3.685

Review 3.  Therapeutic Potential of Astrocyte Transplantation.

Authors:  Nataly Hastings; Wei-Li Kuan; Andrew Osborne; Mark R N Kotter
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

Review 4.  Astrocytes in Neurodegeneration: Inspiration From Genetics.

Authors:  Jingxuan Huang; Chunyu Li; Huifang Shang
Journal:  Front Neurosci       Date:  2022-06-24       Impact factor: 5.152

5.  Evidence of traumatic brain injury in headbutting bovids.

Authors:  Nicole L Ackermans; Merina Varghese; Terrie M Williams; Nicholas Grimaldi; Enna Selmanovic; Akbar Alipour; Priti Balchandani; Joy S Reidenberg; Patrick R Hof
Journal:  Acta Neuropathol       Date:  2022-05-17       Impact factor: 15.887

6.  Putative dendritic correlates of chronic traumatic encephalopathy: A preliminary quantitative Golgi exploration.

Authors:  Allysa Warling; Riri Uchida; Hyunsoo Shin; Coby Dodelson; Madeleine E Garcia; N Beckett Shea-Shumsky; Sarah Svirsky; Morgan Pothast; Hunter Kelley; Cynthia M Schumann; Christine Brzezinski; Melissa D Bauman; Allyson Alexander; Ann C McKee; Thor D Stein; Matthew Schall; Bob Jacobs
Journal:  J Comp Neurol       Date:  2020-09-23       Impact factor: 3.215

Review 7.  Identifying degenerative effects of repetitive head trauma with neuroimaging: a clinically-oriented review.

Authors:  Breton M Asken; Gil D Rabinovici
Journal:  Acta Neuropathol Commun       Date:  2021-05-22       Impact factor: 7.801

8.  Altered oligodendroglia and astroglia in chronic traumatic encephalopathy.

Authors:  K Blake Chancellor; Sarah E Chancellor; Joseph E Duke-Cohan; Bertrand R Huber; Thor D Stein; Victor E Alvarez; Benjamin W Okaty; Susan M Dymecki; Ann C McKee
Journal:  Acta Neuropathol       Date:  2021-05-21       Impact factor: 15.887

9.  Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.

Authors:  Pashtun Shahim; Adam Politis; Andre van der Merwe; Brian Moore; Vindhya Ekanayake; Sara M Lippa; Yi-Yu Chou; Dzung L Pham; John A Butman; Ramon Diaz-Arrastia; Henrik Zetterberg; Kaj Blennow; Jessica M Gill; David L Brody; Leighton Chan
Journal:  Neurology       Date:  2020-07-08       Impact factor: 9.910

10.  Mouse closed head traumatic brain injury replicates the histological tau pathology pattern of human disease: characterization of a novel model and systematic review of the literature.

Authors:  Aydan Kahriman; James Bouley; Thomas W Smith; Daryl A Bosco; Amanda L Woerman; Nils Henninger
Journal:  Acta Neuropathol Commun       Date:  2021-06-29       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.